WO2018057808A1 - Benzimidazole derivatives and their use as phosphatidylinositol 3-kinase inhibitors - Google Patents

Benzimidazole derivatives and their use as phosphatidylinositol 3-kinase inhibitors Download PDF

Info

Publication number
WO2018057808A1
WO2018057808A1 PCT/US2017/052817 US2017052817W WO2018057808A1 WO 2018057808 A1 WO2018057808 A1 WO 2018057808A1 US 2017052817 W US2017052817 W US 2017052817W WO 2018057808 A1 WO2018057808 A1 WO 2018057808A1
Authority
WO
WIPO (PCT)
Prior art keywords
yl
1h
cancer
nr
morpholino
Prior art date
Application number
PCT/US2017/052817
Other languages
French (fr)
Other versions
WO2018057808A8 (en
Inventor
Jayaraman Chandrasekhar
Julian Andrew CODELLI
Devan Naduthambi
Leena Patel
Stephane Perreault
Gary Phillips
Kassandra F. SEDILLO
Jennifer Anne TREIBERG
Joshua Van Veldhuizen
William J. Watkins
Original Assignee
Gilead Sciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201662398744P priority Critical
Priority to US62/398,744 priority
Application filed by Gilead Sciences, Inc. filed Critical Gilead Sciences, Inc.
Publication of WO2018057808A1 publication Critical patent/WO2018057808A1/en
Publication of WO2018057808A8 publication Critical patent/WO2018057808A8/en

Links